CRSR
Corsair Gaming, Inc.
CRSR's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CRSR overall, supported by stronger valuation and stronger fundamentals.
CRSR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
CRSR's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CRSR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 16x | $12.28 | — |
| Cheap | 18x | $7.00 | -43% |
| Fair | 30x | $11.35 | -7.5% |
| Current | 32x | $12.28 | — |
| Expensive | 99x | $37.59 | +206% |
Historical ranges are pointers, not guarantees.
CRSR's PE is in its fair range at 32x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over CRSR in the historical PE scenario, which offers more potential upside but is not a forecast.
CRSR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
CRSR has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CRSR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.79 | +107% |
| Q3 2026 | $0.38 | +$0.72 |
| Q2 2026 | $0.31 | +$1.12 |
| Q1 2026 | $0.09 | +$1.02 |
| Q4 2025 | -$0.12 | +$0.83 |
| Q3 2025 | -$0.34 | +$0.62 |
| Q2 2025 | -$0.81 | -$0.38 |
| Q1 2025 | -$0.93 | -$0.79 |
| Q4 2024 | -$0.95 | -$0.92 |
CRSR has returned to profit: it earned $0.38 per share over the past year, after losing money the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CRSR on earnings, with more consistent year-over-year improvement.
CRSR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $367M | +6.1% |
| Q2 2026 | $314.3M | -1.8% |
| Q1 2026 | $354.5M | -4.1% |
| Q4 2025 | $436.9M | +5.6% |
| Q3 2025 | $345.8M | +14% |
| Q2 2025 | $320.1M | +23% |
| Q1 2025 | $369.8M | +9.6% |
| Q4 2024 | $413.6M | -0.9% |
CRSR's revenue is recovering but still below its 2020 peak: $367M last quarter, up 6.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +1.2 points |
| Q2 2026 | 2.4% | +7.7 points |
| Q1 2026 | 3.9% | +4.5 points |
| Q4 2025 | 6.2% | +4.7 points |
| Q3 2025 | -1.6% | +5.3 points |
| Q2 2025 | -5.3% | +4.2 points |
| Q1 2025 | -0.6% | +2.4 points |
| Q4 2024 | 1.4% | -1.5 points |
CRSR's operating margin was −0.5% last quarter, up 1.2 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CRSR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CRSR on profitability, with a higher operating margin.
CRSR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$16.7M | +$24.6M |
| Q2 2026 | $72.1M | +162% |
| Q1 2026 | $26.1M | +66% |
| Q4 2025 | $32.9M | -39% |
| Q3 2025 | -$41.3M | -290% |
| Q2 2025 | $27.5M | +$48.5M |
| Q1 2025 | $15.7M | +$44.5M |
| Q4 2024 | $54.1M | -1.9% |
CRSR usually generates cash, though not every quarter: the latest was −$17M, but it generated $114M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CRSR on cash flow, with more consistent year-over-year improvement.
CRSR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -487K shares |
| 1 year | +2.3% | +2.4M shares |
| 3 years | +5.7% | +5.8M shares |
| 5 years | +8.7% | +8.7M shares |
| Available history | +18% | +16.9M shares |
CRSR has 109M diluted shares, up 2.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $5M |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | $962,000 |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over CRSR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CRSR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -1.3x | Net Cash |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | 1.5x | Healthy |
| Q2 2024 | 11.2x | High |
| Q1 2024 | 1.4x | Healthy |
| Q4 2023 | 0.4x | Very low |
| Q3 2023 | 1.3x | Healthy |
CRSR has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CRSR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.5 | Neutral |
| Stochastic | 40.1 | Neutral |
CRSR's weekly RSI is 55 (neutral) and its Stochastic is 40 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CRSR PE vs Technology Sector
| Metric | CRSR | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 28x | 16% above |
| PE % | 55 | 38 | 17 pts above |
CRSR is trading at 32x earnings, a 16% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over CRSR on valuation relative to its sector.
CRSR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.0 | 5.8% below |
| 20 week MA | $12.2 | 1.1% above |
| 50 week MA | $8.83 | 39% above |
| 100 week MA | $8.67 | 42% above |
| 200 week MA | $10.8 | 14% above |
CRSR has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CRSR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.3 | $36.4 | +111% |
| 2021 | $36.4 | $22.4 | -38% |
| 2022 | $22.4 | $13.7 | -39% |
| 2023 | $13.7 | $14.1 | +2.6% |
| 2024 | $14.1 | $6.55 | -54% |
| 2025 | $6.55 | $6.10 | -6.9% |
| 2026 YTD | $6.10 | $12.3 | +101% |
CRSR has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.